Is there an indication for an Implantable Cardioverter-Defibrillator (ICD) for a patient with sudden cardiac death, no coronary artery disease, left ventricular ejection fraction (LVEF) of 37%, and a history of pulseless electrical activity (PEA) arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2025 • View editorial policy

From the Guidelines

An implantable cardioverter-defibrillator (ICD) is not indicated for this patient with sudden cardiac death, no coronary artery disease, left ventricular ejection fraction (LVEF) of 37%, and a history of pulseless electrical activity (PEA) arrest. The patient's condition does not meet the standard criteria for ICD implantation, as PEA arrests are not typically shockable rhythms and the patient's LVEF is above the threshold of ≤35% used for primary prevention ICD implantation in patients with heart failure 1.

Key Considerations

  • The absence of coronary artery disease suggests that the cardiac arrest may have been due to non-arrhythmic causes such as respiratory failure, pulmonary embolism, or metabolic disturbances, which would not be prevented by an ICD.
  • ICDs are primarily beneficial for patients with ventricular tachyarrhythmias (ventricular tachycardia or ventricular fibrillation) that can be terminated by delivering a shock, which is not the case in PEA arrests.
  • The focus should be on identifying and treating the underlying cause of the PEA arrest and optimizing heart failure management with guideline-directed medical therapy, rather than implanting an ICD.

Relevant Guidelines

  • The European Society of Cardiology guidelines recommend ICD implantation in patients who have survived cardiac arrest or have sustained ventricular tachycardia, but this does not apply to PEA arrests 1.
  • The American College of Cardiology guidelines also discuss the use of ICDs in patients who are not included or not well represented in clinical trials, but do not provide a clear indication for ICD implantation in patients with PEA arrests 2.

From the Research

Indications for Implantable Cardioverter-Defibrillator (ICD)

  • The patient has a history of sudden cardiac death, no coronary artery disease, and a left ventricular ejection fraction (LVEF) of 37%, which is below the normal range.
  • According to 3, current guidelines for ICD implantation are based primarily on an ejection fraction (EF) <30%-35%, but the patient's LVEF of 37% is close to this threshold.
  • The patient also has a history of pulseless electrical activity (PEA) arrest, which increases the risk of sudden cardiac death.

Risk Stratification

  • Studies have shown that patients with low LVEF are at increased risk for sudden cardiac death, but other factors such as reduced repolarization reserve and altered sympathetic/parasympathetic balance can also contribute to this risk 3.
  • Electrocardiogram-based predictors, such as signal-averaged ECG and T-wave alternans, can provide additional information on the underlying cardiac substrate abnormality that may predispose to ventricular arrhythmias and sudden cardiac death 4.
  • The absence of coronary artery disease in this patient may affect the risk stratification, as coronary artery disease is a major risk factor for sudden cardiac death 5.

ICD Implantation

  • ICD implantation is effective at terminating malignant arrhythmias and can reduce the risk of sudden cardiac death 5, 6.
  • However, the decision to implant an ICD should be based on individual patient characteristics, including LVEF, medical history, and other risk factors 3, 4.
  • In this case, the patient's history of PEA arrest and low LVEF may indicate a potential benefit from ICD implantation, but further evaluation and consideration of other risk factors are necessary to make an informed decision 7, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.